LunaRich Graduates from MPSC

CongratsGradLR-web

SubscribeButton-web

 

 

New manufacturing and research structure maintains product quality, facilitates research and fosters continued innovation.

By Andrew Birney, Chief Operating Officer of SL Technology, Inc., a wholly owned Reliv subsidiary

Change is the product of innovation. As Reliv’s innovation engine, SL Technology understands that change is a positive force, especially in the dynamic, fast-paced, ever-changing world of the global nutrition industry. Not only does the technology change rapidly, but so do business relationships and industry objectives.

The past three years have been a whirlwind of change for SL Tech (formerly Soy Labs). Since moving to the Missouri Plant Science Center (MPSC) facility in 2011, Soy Labs has thrived in the culture of open innovation fostered there. Access to the MPSC labs and processing equipment provided the necessary tools to develop and refine the method of production for the first commercially available form of the lunasin peptide. Continue reading “LunaRich Graduates from MPSC”

Reliv’s ‘Dynamic Duo’ Rocks Geneva Convention

SubscribeButton-web

S&HTVitaFoods-webThe Reliv Now® and LunaRich X™ study stole the show last month at the Vitafoods Europe Conference in Geneva, Switzerland. Dr. Alfredo Galvez’s presentation on the results from the University of Missouri study, which shows that the combination of these two products supports weight loss, heart health, and metabolic wellness, was perhaps the most popular presentation of the entire symposium. Continue reading “Reliv’s ‘Dynamic Duo’ Rocks Geneva Convention”

The LunaRich Opportunity: Right Place, Right Time

I launched Soy Labs in 2005 as a way to bring lunasin technology to the world. Research had already established many of lunasin’s benefits; the challenge was to create a product that both optimized lunasin content and delivered it in the most bioavailable form. Continue reading “The LunaRich Opportunity: Right Place, Right Time”